Products manufactured at the new Vaughan facility will support research in areas including cancer, infectious disease, mental health, and environmental safety
Facility designed to advance the next generation of imaging systems
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The expansion will significantly enhance AbbVie’s ability to meet growing global demand for biologics, particularly in oncology and immunology
Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use
Subscribe To Our Newsletter & Stay Updated
